Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail
-

Topicort (desoximetasone) ointment

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – May 2010

 

Summary View

 

PRECAUTIONS
Carcinogenesis, Mutagenesis, and Impairment of Fertility
  • Desoximetasone was nonmutagenic in the Ames test.
-
-